Raghuveer Singh Mali

Inhibition of Inflammatory Signaling in Tet2 Mutant Preleukemic Cells Mitigates Stress-Induced Abnormalities and Clonal Hematopoiesis

Zhigang Cai, Jonathan J. Kotzin, Baskar Ramdas et al. · Cell stem cell · 2018 · 368 citations · Full text

Inflammation, Cytokine, T-regulatory Cell +11

Venetoclax combines synergistically with FLT3 inhibition to effectively target leukemic cells in FLT3-ITD+ acute myeloid leukemia models

Raghuveer Singh Mali, Qi Zhang, RosaAnna DeFilippis et al. · Haematologica · 2020 · 134 citations · Full text

Venetoclax Monotherapy, Hematological Malignancy, Venetoclax Combines +15

Therapeutic Potential of Targeting the Oncogenic SHP2 Phosphatase

Li‐Fan Zeng, Ruo-Yu Zhang, Zhi-Hong Yu et al. · Journal of Medicinal Chemistry · 2014 · 131 citations · Full text

Chemoprevention Strategy, Shp2 Active Site, Cancer Biology +22

Single Nucleotide Polymorphism Array Lesions, TET2, DNMT3A, ASXL1 and CBL Mutations Are Present in Systemic Mastocytosis

Fabı́ola Traina, Valeria Visconte, A. Jankowska et al. · PLoS ONE · 2012 · 116 citations · Full text

Mast Cell Disorder, Genetics, Systemic Mastocytosis +16

Rho Kinase Regulates the Survival and Transformation of Cells Bearing Oncogenic Forms of KIT, FLT3, and BCR-ABL

Raghuveer Singh Mali, Baskar Ramdas, Peilin Ma et al. · Cancer Cell · 2011 · 96 citations · Full text

Signal Transduction, Signaling Pathway, Rho Kinase +8